Last reviewed · How we verify
BGP-014
At a glance
| Generic name | BGP-014 |
|---|---|
| Sponsor | BioGaia Pharma AB |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |